Inflammatory Bowel Disease (IBD) Management Challenges Symposium 2016
In-Person Event
Sep 17, 2016
Seattle, Washington, USA
OVERVIEW
The management of IBD is highly dynamic with extensive, cutting-edge information deriving from a wealth of ongoing scientific, clinical, and therapeutic research programs.
Current Challenges in IBD Management 2016 a CME Symposium designed to address educational needs identified by gastroenterologists, gastroenterology nurses, radiologists and surgeons involved in the care of patients with IBD residing in the northwest United States.
The mission of IBD Horizons is to provide healthcare providers the opportunity to enhance their clinical knowledge by providing the most up-to-date information regarding the management of IBD. Cutting edge topics delivered by respected educators/leaders in the IBD field, as well as opportunities for interaction between the presenters and participants have been designed into the educational program.
Objectives:
• Assess the latest evidenced-based information on growth preserving medical and surgical management of IBD in pediatric patients.
• Analyze the effectiveness of biologics and predictors of response in order to optimize the management of patients with moderate-to-severe Crohn's disease.
• Assess the evidence regarding the role of therapeutic drug monitoring in order to optimize response to biologics in patients with IBD.
• Examine the efficacy and role of calcineurin inhibitors and biologics in patients with steroid-refractory ulcerative colitis.
• Evaluate the available data on azathioprine and methotrexate in order to optimize their use in patients with steroid-refractory IBD.
• Summarize the available evidence on where serological testing has the greatest benefit in the diagnostic algorithm of IBD.
• Apply the most recent evidence-based information regarding the reprodudive safety of IBD therapies when counseling patients who are considering pregnancy or who are pregnant.
• Describe the available medical and surgical data concerning the treatment of patients with c omplex perianal CD.
• Evaluate new and emerging therapies for the management of IBD in order to respond to caregiver questions and to refer patients to clinical trials.
Current Challenges in IBD Management 2016 a CME Symposium designed to address educational needs identified by gastroenterologists, gastroenterology nurses, radiologists and surgeons involved in the care of patients with IBD residing in the northwest United States.
The mission of IBD Horizons is to provide healthcare providers the opportunity to enhance their clinical knowledge by providing the most up-to-date information regarding the management of IBD. Cutting edge topics delivered by respected educators/leaders in the IBD field, as well as opportunities for interaction between the presenters and participants have been designed into the educational program.
Objectives:
• Assess the latest evidenced-based information on growth preserving medical and surgical management of IBD in pediatric patients.
• Analyze the effectiveness of biologics and predictors of response in order to optimize the management of patients with moderate-to-severe Crohn's disease.
• Assess the evidence regarding the role of therapeutic drug monitoring in order to optimize response to biologics in patients with IBD.
• Examine the efficacy and role of calcineurin inhibitors and biologics in patients with steroid-refractory ulcerative colitis.
• Evaluate the available data on azathioprine and methotrexate in order to optimize their use in patients with steroid-refractory IBD.
• Summarize the available evidence on where serological testing has the greatest benefit in the diagnostic algorithm of IBD.
• Apply the most recent evidence-based information regarding the reprodudive safety of IBD therapies when counseling patients who are considering pregnancy or who are pregnant.
• Describe the available medical and surgical data concerning the treatment of patients with c omplex perianal CD.
• Evaluate new and emerging therapies for the management of IBD in order to respond to caregiver questions and to refer patients to clinical trials.
KEY DATES
17 Sep, 2016
Event Start Date
17 Sep, 2016
Event End Date
SPECIALITIES
GastroenterologySUGGESTED HOTELS
CONFERENCE VENUE
Bell Harbor International Conference Center
RELATED CONFERENCES & LIVE WEBINARS
Quick Links